Diphenhydramine has been in medical use for 35 years äs an antihistamine and hypnotic. We evaluated the pharmacokinetic parameters, which are not only important for disposition studies, in the serum of 10 volunteers who received a single dose of 31 mg diphenhydramine.
Introduction
antiemet j c and se dative properties, the last For well over 35 years diphenydramine hydrochlo-mentioned leading to its widespread use äs a drug for ride (I)* has been used medicälly äs an antihistamine inducing sleep (2, 3) : and hypnotic (1) . Chemically it is 2-(diphenylmethoxy)-N,N-dimethylethylamine and possesses anticholinergic, antitus-* in the U.S.: Benadryl® (Parke-Davis) ^^î n Germany: Betadorm^-A (Woelm Pharma) Diphenhydramine (I) in Switzerland: Detensor® (Sandoz) Diphenhydramine is rapidly and well absorbed with a systemic bioavailability of at least 50% after oral application (4, 5) . Maximal plasma concentrations are reached after one to four hoiirs (6, 7) ; an apparent plasma half-life of about 3-10 hours is reported (4).
Average peak plasma levels (after a therapeutic dose of 50 mg) were about 80-100 [ig/l (3-7). The biotransformation of I is well documented in the literature (8); the major metabolite in human plasma and urine was identified s diphenylmethoxyacetic acid (9) .
Analytical Methods
Many analytical approaches have been published for the identifU cation/detection of diphenhydramine, e.g. paper-, thin layer-and column-chromatography, electrophoresis, colorimetric/fluorometric and titrimetric analysis (10) (11) (12) . These, however are not specific and sensitive enough for determinations in biological fluids (urine, plasma/serum).
The published GC, GC-MS and HPLC-methods are obviously more reliable. Unfortunately they often include extensive, time consuming preparations (e.g. special sample clean-up), involving conversion or formation of derivatives (13) and/or operate near the limit of sensitivity. Some methods do not distinguish between the unchanged drug and its metabolites or are prone to interferences (6) .
All the published GC-methods use packed columns and flame ionization detectors (FID), which limits sensitivity to about 10-20 mg/1 (2, 4, 7, 11, 14) ; recently published methods employ more selective detectors, e.g. the nitrogen specific detector (N-FID) (6).
Vessman et al. (13) successfully used the electron capture detector (ECD), but their sample clean-up includes e.g. conversion of diphenhydramine to benzophenone, a rather time-consuming and inconvenient procedure. Liquid-chromatographic assays have onl y been applied to aqueous samples and/or are not applicable for rapid (screening) procedures (15, 16) . The published gas chromatographic-mass fragmentographic method using single-ion-recording (SIR) of the characteristic ion at m/z 165 fulfills the requirements for a reliable assay but is less suitable for some metabolites (e.g. the N-oxide and the diphenylmethoxyacetic acid) which are either thermolabile or not volatile enough (17, 18) ; furthermore this method is relatively expensive and often not readily available in a clinical laboratory.
Results and Biscussion of our own investigations
With some exceptions we followed the GC-method published by Baugh & Calvert (7); a five-fold increase of the detection limit could be achieved by employing a capillary column instead of a packed column.
Extraction
To 3 ml of serum in a centrifuge tube (fitted with a teflon lined cap) 10 μΐ of a methanolic solution of the internal Standard (14 μg/l) are added and thoroughly mixed (Vortex) for 10 seconds.
After adding l ml of sodium hydroxide (l mol/1) and 7 ml /i-heptane, the mixture is extracted for one hour in an Inversion shaker. After centrifuging, the organic layer is transferred to a coriic l tube and evaporated to dryness under nitrogen at 55 °C. The residue is reconstituted in 40 μΐ acetone, concentrated to approx. 10 μΐ and l μΐ is injected in the GC.
GC-conditions
The GC analysis is carried out using a Carlo Erba FV 2150 Chromatograph equipped with an nitrogen selective detector (N^FID). 
Column

Conclusions
The presented capillary GC-method allows the fast and accurate quantitative determination of either diphenhydramine or orphenadrine and other ethanolamines in human serum. It is also clear from the chromatogram ( fig. 1 ) that capillary columns provide more than adequate efficiency, sensitivity and selectivity.
The combination of a rather non-polar extraction solvent and a selective detector eliminates the need for e. g. a back extraction or further Steps in sample clean-up.
A calibration curve was established and checked to be linear between 2.5 and 120 g/l serum; the detection limit of 2 g/l clearly shows the reliability of the assay. Average recovery based on 5 determinations (at 14 g/l) was about 100.1% (C.V. = 4.9%); reproducibility between duplicate injections was always better than 3.6%.
